术后3个月最佳矫正视力与术前相比无1例下降，58眼最佳矫正视力提高1或2行。
The best corrected visual acuity did not decrease 3 months after operations, and it was raised 1 or 2 lines in 58 eyes.
深板层角膜移植组术后裸眼视力平均提高4行，最佳矫正视力平均提高7行，无排斥反应发生。
ResultsIn deep lamellar keratoplasty group, postoperatively the patients saw 4 lines more with no correction, 7 lines more with best correction and there was no rejection.
研究小组记录到：治疗后平均K值、SE和RMS误差降低，同时裸眼视力和最佳矫正视力提高了几行，并且两组患者角膜厚度增加，没有观察到角膜内皮细胞的丢失（表1）。
The team recorded a decrease in mean K, SE and RMS error, whilst lines were gained in UCVA and BSCVA, and pachymetry increased with no endothelial cell loss being observed in either group (Table 1).
治疗效果：所有患者达到预期最佳矫正视力，其中超过预期矫正视力2行以上者为51.1%(24眼)，超过3行以上者为23.4%(11眼)。
Therapeutic effect: all the patients achieved expected best corrected visual acuity, 51.1% of them (24 eyes) were 2 lines better than expected, and 23.4% (11 eyes) were 3 lines better.
结果：深板层角膜移植组术后裸眼视力平均提高4行，最佳矫正视力平均提高7行，无排斥反应发生。
RESULTS:In deep lamellar keratoplasty group, postoperatively the patients saw 4 lines more with no correction, 7 lines more with best correction and there was no rejection.
穿透角膜移植术后裸眼视力平均提高5行，最佳矫正视力平均提高8行，有5例发生排斥反应。
In penetrating keratoplasty group, postoperatively the patients saw 5 lines more with no correction, 8 lines more with best correction and there were five patients had rejection.
穿透角膜移植术后裸眼视力平均提高5行，最佳矫正视力平均提高8行，有5例发生排斥反应。
In penetrating keratoplasty group, postoperatively the patients saw 5 lines more with no correction, 8 lines more with best correction and there were five patients had rejection.
应用推荐